Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas

被引：0
|
作者：
Carsten Zwick
Gerhard Held
Vera Hammermeister
Adnan AlAhmad
Boris Kubuschok
Joerg Bittenbring
Manfred Ahlgrimm
Frank Neumann
Klaus-Dieter Preuss
Michael Pfreundschuh
机构：
[1] Saarland University Medical School Homburg,Innere Medizin I, Jose
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Aggressive lymphomas; BCL-2; Immunogenicity; Antibody response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1207 / 1213
页数：6
相关论文
共 50 条
  • [1] Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas
    Zwick, Carsten
    Held, Gerhard
    Hammermeister, Vera
    AlAhmad, Adnan
    Kubuschok, Boris
    Bittenbring, Joerg
    Ahlgrimm, Manfred
    Neumann, Frank
    Preuss, Klaus-Dieter
    Pfreundschuh, Michael
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (09) : 1207 - 1213
  • [2] Allogeneic stem cell transplantation induces high-titered antibody responses to cancer testis antigens in multiple myeloma patients
    Kobold, S.
    Cao, Y.
    Tams, S.
    Bartels, B. M.
    Eberhard, C.
    Luetkens, T.
    Pabst, C.
    Bokemeyer, C.
    Kroeger, N.
    Atanackovic, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 569 - 569
  • [3] In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
    Mason, Kylie D.
    Vandenberg, Cassandra J.
    Scott, Clare L.
    Wei, Andrew H.
    Cory, Suzanne
    Huang, David C. S.
    Roberts, Andrew W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (46) : 17961 - 17966
  • [4] REARRANGEMENT OF BCL-2 GENES IN MALIGNANT-LYMPHOMAS IN CHINESE PATIENTS
    CHEN, PM
    LIN, SH
    SETO, M
    CHAO, SC
    CHIOU, TJ
    HSIEH, RK
    LIN, CZ
    FAN, S
    TZENG, CH
    UEDA, R
    LIU, JH
    CANCER, 1993, 72 (12) : 3701 - 3706
  • [5] Inhibition of cell growth and bcl-2 expression in aggressive B-cell lymphomas by retinoic acid.
    Sundaresan, A
    Claypool, CK
    LopezBerestein, G
    Cabanillas, F
    Ford, RJ
    BLOOD, 1995, 86 (10) : 2400 - 2400
  • [6] Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients
    Camilleri-Broët, S
    Camparo, P
    Mokhtari, K
    Xuan, KH
    Martin, A
    Arborio, M
    Hauw, JJ
    Raphaël, M
    MODERN PATHOLOGY, 2000, 13 (02) : 158 - 165
  • [7] A targeted molecular classifier of MYC activity and BCL-2 expression in aggressive B-cell lymphomas, designed for clinical practice
    Carey, Christopher D.
    Gusenleitner, Daniel
    Chapuy, Bjoern
    Sun, Heather
    Ligon, Azra
    Kovach, Alexandra E.
    Le, Long P.
    Sohani, Aliyah R.
    Shipp, Margaret
    Monti, Stefano
    Rodig, Scott J.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Bcl-2 and bax protein expression in indolent versus aggressive B-Cell non-Hodgkin's lymphomas
    Wheaton, S
    Netser, J
    Guinee, D
    Rahn, M
    Perkins, S
    HUMAN PATHOLOGY, 1998, 29 (08) : 820 - 825
  • [9] Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma
    D. Fassnacht
    S. Rössing
    R. P. Singh
    M. Al-Rubeai
    R. Pörtner
    Cytotechnology, 1999, 30 : 95 - 106
  • [10] Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma
    Fassnacht, D
    Rössing, S
    Singh, RP
    Al-Rubeai, M
    Pörtner, R
    CYTOTECHNOLOGY, 1999, 30 (1-3) : 95 - 105
12345